Who to call at IMMUCELL CORP /DE/, and when
Fundz watches for the moments IMMUCELL CORP /DE/ starts buying, and tells you who to reach.
- An alert the day IMMUCELL CORP /DE/ raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at IMMUCELL CORP /DE/, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at IMMUCELL CORP /DE/. With Fundz connected, it knows.
IMMUCELL CORP /DE/
A senior executive or director joined, left, or changed roles. An 8-K is the notice a US public company must file within four business days of a major event.
immucell.comAI Executive Summary
AI-powered analysis of 8-K filing content
IMMUCELL Corp's Board expanded from seven to nine directors, and Olivier te Boekhorst became President and CEO effective November 1, 2025, succeeding Michael F. Brigham, who remains as Special Advisor to the CEO. CFO Timothy C. Fiori was also elected a director and Secretary and Treasurer, so the change in top leadership and governance may affect the company's strategic direction.
Key Takeaways
Olivier te Boekhorst assumed the President and CEO role on November 1, 2025, replacing Michael F. Brigham, who stepped down from the CEO, Secretary, and Treasurer positions.
Brigham remains with the company as Special Advisor to the CEO, which may provide continuity during the transition.
3 more takeaways
Related Filings (8)
8 more filings from IMMUCELL CORP /DE/ in the last 90 days
Filing Overview
What This Means
IMMUCELL CORP /DE/ filed with the SEC. Fundz turns 8-K material events into an alert with the right executive attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
4 screens from a live account. No signup.